Animal Vaccines Market worth $8.6 Billion by 2018 The “"Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018", analyzes and studies the major market drivers, restraints, and opportunities in Europe, North America, Asia, and the Rest of the World. Browse 99 market data tables and 50 figures spread through 281 pages and in-depth TOC on “Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018”. http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html Early buyers will receive 10% customization on this report. The global veterinary vaccines market will be valued at $5.8 billion in 2013 and is expected to reach $8.6 billion by 2018, growing at a healthy CAGR of 8.1% from 2013 to 2018. Download Free Sample PDF: http://www.marketsandmarkets.com/pdfdownload.asp?id=1233 The studied is segmented by products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration. The global market, by products, is further segmented into seven segments, namely, companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other veterinary vaccines. In 2012, vaccines of livestock and porcine were two of the largest segments, accounting for 63% of the market share globally. The livestock vaccines market is further segmented into vaccines for bovine and small ruminant, whereas the companion animal vaccines market is further segmented into canine vaccines and feline vaccines. Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1233 On the basis of technology, the animal vaccines market has segments like live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines technology will be the fastest-growing technology due to its cost effectiveness and easy production, rapid development against emerging diseases, and added thermo-stability between 4°C to 20°C in comparison with traditional vaccines. Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=1233 The global animal vaccines market, valued at $5.4 billion in 2012, is primarily driven by factors such as the growing prevalence of animal diseases, increasing incidences of zoonotic diseases in humans, increasing investments by government bodies and animal welfare associations,, and continuous innovations and introductions of new products. On the other hand, factors such as increasing maintenance costs for vaccines and consumers’ increasing preference for vegetarian food to avoid obesity will restrict the growth of the market. Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva
(France) are the key players in the global animal vaccines market. Most of these companies have established their foothold in the market and new entrants will face challenges as far as making a mark in the industry is concerned. Additionally, stringent regulatory guidelines and the capital-intensive nature of the industry will make entry more difficult for new companies. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: sales@marketsandmarkets.com